Disordered follicle development
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Alterations of ovarian follicle morphology and function have been well documented in women with PCOS. These include increased numbers of growing preantral follicles, failure of follicle growth beyond the mid-antral stage, evidence of granulosa call degeneration, and theca cell hyperplasia. Functional abnormalities include paradoxical granulosa cell hyperresponsiveness to FSH which is clinically linked to ovarian hyperstimulation during ovulation induction. In addition, there is likely a primary theca cell defect that accounts for the majority of excess androgen production in this disorder. The precise mechanisms responsible for altered follicle function are not completely clear. However, several factors appear to influence normal advancement of follicle development as well as impair ovarian steroidogenesis. These include intra- as well as extraovarian influences that distort normal ovarian growth and disrupt steroid production by follicle cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Androgens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712 · cited 2×
“Subsequent studies have revealed that, in GCs of non-human primates with implanted silastic capsules containing testosterone, FSH receptor expression was increased and co-localized with that of the androgen receptor (Vendola et al., 1998; Weil et al., 1999).”
Androgen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · cited 2×
“The association between hyperinsulinemia and hyperandrogenemia in women with PCOS might be explained by the finding that the activity of a single serine kinase may result in both hyperandrogenemia and insulin resistance as it appears to phosphorylate CYP17, activating androgen production, as well as the insulin recept…”
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Willis, D., Mason, H., Gilling-Smith, C., & Franks, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550768 · Cited by 371 · cited 3×
“Incubation with insulin alone was associated with increased E2 and P4 production from GCs of normal ovaries as well as those from ovulatory and anovulatory PCOS ovaries (Willis et al., 1996).”
Barnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304 · cited 2×
“Among local factors that might accelerate follicle growth, androgen excess is suggested from polycystic ovary morphology associated with hyperandrogenic women with congenital adrenal hyperplasia or androgen-producing ovarian tumors (Dunaif et al., 1984; Erickson et al., 1989; Barnes et al., 1994).”
Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome
Gilling‐Smith, C., Story, H., Rogers, V., & Franks, S. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2321049.x · Cited by 301 · cited 2×
“…study of PCOS women showed that 17-OHP production in response to human chorionic gonadotropin (hCG), a surrogate for LH stimulation, was elevated compared to that of normal women and remained amplified following suppression of endogenous gonadotropins by GnRH agonist (Gilling-Smith et al., 1997).”
Dunaif, A., & Graf, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113864 · Cited by 204 · cited 1×
“However, induction of marked hyperinsulinemia in women with PCOS has not been associated with increases in serum androgen levels (Nestler et al., 1987; Dunaif and Graf, 1989).”
Research works printed but not linked: 70
- Adashi, 1982, Estrogens augment the stimulation of ovarian aromatase activity by follicle-stimulating hormone in cultured rat granulosa cells, J. Biol. Chem., 257, 6077, 10.1016/S0021-9258(20)65107-9 · DOI · Paper page
- Almahbobi, 1996, Functional integrity of granulosa cells from polycystic ovaries, Clin. Endocrinol., 44, 571, 10.1046/j.1365-2265.1996.724545.x · DOI · Paper page
- Barbieri, 1984, Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca, Obstet. Gynecol., 64, 73S, 10.1097/00006250-198409001-00019 · DOI · Paper page
- Barbieri, 1986, Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism, J. Clin. Endocrinol. Metab., 62, 904, 10.1210/jcem-62-5-904 · DOI · Paper page
- Barnes, 1989, Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome, N. Engl. J. Med., 320, 559, 10.1056/NEJM198903023200904 · DOI · Paper page
- Bergh, 1993, Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin, Fertil. Steril., 59, 323, 10.1016/S0015-0282(16)55675-1 · DOI · Paper page
- Bremer, 2008, The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance, Fertil. Steril., 89, 1039, 10.1016/j.fertnstert.2008.02.091 · DOI
- Cara, 1988, Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells, Endocrinology, 123, 733, 10.1210/endo-123-2-733 · DOI · Paper page
- Chadha, 1994, Androgen receptor expression in human ovarian and uterine tissue of long term androgen-treated transsexual women, Human Path., 25, 1198, 10.1016/0046-8177(94)90037-X · DOI
- Chang, 1982, Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease, J. Clin. Endocrinol. Metab., 54, 490, 10.1210/jcem-54-3-490 · DOI · Paper page
- Coffler, 2003, Evidence for abnormal granulosa cell responsiveness to follicle stimulating hormone in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 88, 1742, 10.1210/jc.2002-021280 · DOI · Paper page
- Coffler, 2003, Enhanced granulosa cell responsiveness to follicle stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone, J. Clin. Endocrinol. Metab., 88, 5624, 10.1210/jc.2003-030745 · DOI
- Daniel, 1980, Enhancement of follicle-stimulating hormone-induced aromatase activity by androgens in cultured rat granulosa cells, Endocrinology, 107, 1027, 10.1210/endo-107-4-1027 · doi:10.1210/endo-107-4-1027
- Daniel, 1983, Involvement of estrogens in the regulation of granulosa cell aromatase activity, Can. J. Physiol. Pharmacol., 61, 507, 10.1139/y83-077 · doi:10.1139/y83-077
- Davoren, 1986, Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action, Endocrinology, 119, 2155, 10.1210/endo-119-5-2155 · DOI
- de Ziegler, 1989, Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease, J. Clin. Endocrinol. Metab., 68, 1111, 10.1210/jcem-68-6-1111 · DOI
- Dong, 1996, Growth differentiation factor-9 is required during early ovarian folliculogenesis, Nature, 383, 531, 10.1038/383531a0 · DOI · Paper page
- Dooley, 2000, Bone morphogenetic protein inhibits ovarian androgen production, J. Clin. Endocrinol. Metab., 85, 3331, 10.1210/jc.85.9.3331 · doi:10.1210/jc.85.9.3331
- Dunaif, 1984, The effects of continuous androgen secretion on the hypothalamic-pituitary axis in women: evidence from a luteinized thecoma of the ovary, J. Clin. Endocrinol. Metab., 59, 389, 10.1210/jcem-59-3-389 · DOI · Paper page
- Erickson, 1978, Stimulation of aromatase activity by follicle stimulating hormone in rat granulosa cells in vivo and in vitro, Endocrinology, 102, 1275, 10.1210/endo-102-4-1275 · DOI
- Erickson, 1984, New data on follicle cells in polycystic ovaries: a proposed mechanism for the genesis of cystic follicles, Semin. Reprod. Endocrinol., 2, 231, 10.1055/s-2008-1068381 · DOI
- Erickson, 1989, Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplasia, Fertil. Steril., 51, 173, 10.1016/S0015-0282(16)60450-8 · DOI
- Erickson, 1990, The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries, J. Clin. Endocrinol. Metab., 70, 894, 10.1210/jcem-70-4-894 · DOI · Paper page
- Fanchin, 2003, Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation, Hum. Reprod., 18, 328, 10.1093/humrep/deg043 · DOI · Paper page
- Futterweit, 1986, Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals, J. Clin. Endocrinol. Metab., 62, 16, 10.1210/jcem-62-1-16 · DOI · Paper page
- Gilling-Smith, 1994, Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries, J. Clin. Endocrinol. Metab., 79, 1158, 10.1210/jc.79.4.1158 · DOI · Paper page
- Glister, 2005, Endocrinology, 146, 1883, 10.1210/en.2004-1303 · DOI
- Grossman, 2008, Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture, Fertil. Steril., 89, 1364, 10.1016/j.fertnstert.2007.03.066 · DOI · Paper page
- Harlow, 1986, Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary, Endocrinology, 119, 1403, 10.1210/endo-119-3-1403 · DOI · Paper page
- Hillier, 1981, Evidence that granulosa cell aromatase induction/activation by follicle- stimulating hormone is an androgen receptor-regulated process in-vitro, Endocrinology, 109, 1303, 10.1210/endo-109-4-1303 · DOI · Paper page
- Hillier, 1991, Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells, Mol. Cell. Endocrinol., 75, R1, 10.1016/0303-7207(91)90234-J · DOI
- Hirshfeld-Cytron, 2009, Characterization of functionally typical and atypical types of polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 94, 1587, 10.1210/jc.2008-2248 · DOI · Paper page
- Hughesdon, 1982, Morphology and morphogenesis of the Stein-Leventhal ovary and of so- called “hyperthecosis”, Obstet. Gynecol. Surv., 37, 59, 10.1097/00006254-198202000-00001 · DOI · Paper page
- Jakimiuk, 2001, Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries, J. Clin. Endocrinol. Metab., 86, 1318, 10.1210/jc.86.3.1318 · DOI · Paper page
- Jia, 1985, Androgen inhibition of follicle-stimulating hormone-stimulated luteinizing hormone receptor formation in cultured rat granulosa cells, Endocrinology, 117, 13, 10.1210/endo-117-1-13 · DOI
- Jonassen, 1982, Enhancement and desensitization of hormone-responsive adenylate cyclase in granulosa cells of preantral and antral ovarian follicles: effects of estradiol and follicle-stimulating hormone, Endocrinology, 111, 74, 10.1210/endo-111-1-74 · DOI
- Kaiser, 1995, A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone, Proc. Natl. Acad. Sci. USA, 92, 12280, 10.1073/pnas.92.26.12280 · DOI · Paper page
- Knecht, 1984, Estrogens enhance the adenosine 3′, 5′-monophosphate-mediated induction of follicle-stimulating hormone and luteinizing hormone receptors in rat granulosa cells, Endocrinology, 115, 41, 10.1210/endo-115-1-41 · doi:10.1210/endo-115-1-41
- La Marca, 2004, Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation, Hum. Reprod., 19, 2738, 10.1093/humrep/deh508 · DOI · Paper page
- Laven, 2001, Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility, Hum. Reprod., 16, 1359, 10.1093/humrep/16.7.1359 · DOI
- Lewis, 2000, Betaglycan binds inhibin and can mediate functional antagonism of activin signalling, Nature, 404, 411, 10.1038/35006129 · DOI · Paper page
- Lindeberg, 2007, Gonadotrophin stimulation of non-luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis, Hum. Reprod., 22, 401, 10.1093/humrep/del408 · DOI
- Maciel, 2004, Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 89, 5321, 10.1210/jc.2004-0643 · DOI · Paper page
- Magoffin, 1998, Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome, Hum. Reprod., 13, 2693, 10.1093/humrep/13.10.2693 · DOI · Paper page
- Mason, 1994, Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid, J. Clin. Endocrinol. Metab., 79, 1355, 10.1210/jc.79.5.1355 · DOI · Paper page
- May, 1980, Follicle-stimulating hormone-mediated induction of functional luteinizing hormone/human chorionic gonadotropin receptors during monolayer culture of porcine granulosa cells, Endocrinology, 107, 1041, 10.1210/endo-107-4-1041 · DOI
- Mehta, 2006, The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 91, 3503, 10.1210/jc.2006-0752 · DOI
- Nahum, 1995, Metabolic regulation of androgen production by human thecal cells in vitro, Hum. Reprod., 10, 75, 10.1093/humrep/10.1.75 · DOI · Paper page
- Nestler, 1987, The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans, J. Clin. Endocrinol. Metab., 64, 180, 10.1210/jcem-64-1-180 · DOI · Paper page
- Pellatt, 2007, Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries, J. Clin. Endocrinol. Metab., 92, 240, 10.1210/jc.2006-1582 · DOI · Paper page
- Rebar, 1976, Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome, J. Clin. Invest., 57, 1320, 10.1172/JCI108400 · DOI · Paper page
- Richards, 1980, Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation, Physiol. Rev., 60, 51, 10.1152/physrev.1980.60.1.51 · DOI · Paper page
- Richards, 1994, Hormonal control of gene expression in the ovary, Endocr. Rev., 15, 725, 10.1210/edrv-15-6-725 · DOI · Paper page
- Richards, 1976, Ovarian follicular development in the rat: hormone receptor regulation by estradiol, follicle stimulating hormone and luteinizing hormone, Endocrinology, 99, 1562, 10.1210/endo-99-6-1562 · DOI · Paper page
- Richards, 1979, Adenosine 3′,5′-monophosphate, luteinizing hormone receptor, and progesterone during granulosa cell differentiation: effects of estradiol and follicle-stimulating hormone, Endocrinology, 104, 765, 10.1210/endo-104-3-765 · DOI
- Rosencrantz, 2011, Clinical evidence for predominance of Delta-5 steroid production in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 96, 1106, 10.1210/jc.2010-2200 · DOI
- Rosenfield, 1994, Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism, J. Clin. Endocrinol. Metab., 79, 1686, 10.1210/jc.79.6.1686 · DOI · Paper page
- Sanders, 1982, Rat granulosa cell differentiation: an in vitro model, Endocrinology, 111, 614, 10.1210/endo-111-2-614 · DOI
- Shimasaki, 2004, The bone morphogenetic protein system in mammalian reproduction, Endocr. Rev., 25, 72, 10.1210/er.2003-0007 · DOI · Paper page
- Spinder, 1989, The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects, J. Clin. Endocrinol. Metab., 69, 151, 10.1210/jcem-69-1-151 · DOI · Paper page
- Stubbs, 2005, Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries, J. Clin. Endocrinol. Metab., 90, 5536, 10.1210/jc.2005-0907 · DOI · Paper page
- Teixeira Filho, 2002, Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 1337, 10.1210/jc.87.3.1337 · doi:10.1210/jc.87.3.1337 · Paper page
- Wachs, 2006, Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women, J. Clin. Endocrinol. Metab., 91, 2920, 10.1210/jc.2006-0442 · DOI
- Wachs, 2008, Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 93, 1827, 10.1210/jc.2007-2664 · DOI
- Webber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016/S0140-6736(03)14410-8 · DOI · Paper page
- Webber, 2007, Prolonged survival in culture of preantral follicles from polycystic ovaries, J. Clin. Endocrinol. Metab., 92, 1975, 10.1210/jc.2006-1422 · DOI · Paper page
- Weenen, 2004, Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment, Mol. Hum. Reprod., 10, 77, 10.1093/molehr/gah015 · DOI · Paper page
- Welt, 2005, Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis, J. Clin. Endocrinol. Metab., 90, 5582, 10.1210/jc.2005-0695 · DOI · Paper page
- Wiater, 2003, Inhibin is an antagonist of bone morphogenetic protein signaling, J. Biol. Chem., 278, 7934, 10.1074/jbc.M209710200 · DOI · Paper page
- Willis, 1998, Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation, J. Clin. Endocrinol. Metab., 83, 3984, 10.1210/jc.83.11.3984 · DOI · Paper page
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Fiorentino, G., Cimadomo, D., Innocenti, F., Soscia, D., Vaiarelli, A., Ubaldi, F. M., Gennarelli, G., Garagna, S., Rienzi, L., & Zuccotti, M. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmac031 · Cited by 176
Genetic determinants of polycystic ovary syndrome: Progress and future directions
Jones, M. R., & Goodarzi, M. O. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.040 · Cited by 117
Endometriosis and polycystic ovary syndrome are diametric disorders
Dinsdale, N. L., & Crespi, B. J. (2021) · Evolutionary Applications · doi:10.1111/eva.13244 · Cited by 90
Li, Y., Deng, B., Ouyang, N., Yuan, P., Zheng, L., & Wang, W. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-0929-z · Cited by 32
“But some patients are insensitive to drugs because of the abnormal basal hormone levels such as the high androgen level, which can affect the growth status of granulosa cells (GCs) [3, 4].”
Background
Metadata
- Authors
- Chang, R. J., & Cook-Andersen, H.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 373
- Issue
- 1-2
- Pages
- 51-60
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2031541454
- Cited by
- 97
- References
- 11
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.